Search for: "ACTAVIS, INC."
Results 161 - 180
of 382
Sorted by Relevance
|
Sort by Date
21 Apr 2011, 11:14 pm
Pliva Inc. [read post]
27 Jul 2016, 8:14 am
Actavis, Inc.,746 F.3d 1371, 1374 (Fed. [read post]
18 Dec 2009, 11:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
27 Aug 2019, 2:03 am
Actavis Labs. [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
26 Mar 2011, 10:00 pm
Mensing (09-1039), and Talk America, Inc. v. [read post]
15 Aug 2016, 8:13 am
Demahy had pursued damages in a Louisiana venue against Actavis, Inc., another maker of the generic drug. [read post]
12 May 2008, 8:59 am
Product Distributed by: Mylan Pharmaceuticals, Inc. under a "Bertek" LabelTherein, we are told that this Digitek recall, at least for Bertek tablets, goes back all the way to March 2006, more than two years before the April 2008 announcements by Actavis and the FDA:Mylan Pharmaceuticals Inc. is continuing a voluntary recall of the Actavis Totowa recall of Digitek ® (digoxin tablets, USP). [read post]
5 Apr 2016, 2:12 am
Actavis, Inc., 133 S. [read post]
4 Jul 2007, 10:50 pm
Actavis then asked for its costs, which Merck was reluctant to pay. [read post]
27 Mar 2008, 8:41 am
The product defect recall by Actavis Inc, the U.S based arm of the international drug manufacturing company Actavis Group hf, is important to note in that it is a total recall of ALL patches manufactured during significant time frame. [read post]
7 Oct 2009, 9:59 pm
Sanofi originally filed suit against Sun, Sandoz, Actavis Inc., and Par Pharmaceutical Inc., among other generic manufacturers, in June 2007, accusing them of infringing Sanofi's patent covering Eloxatin ®, U.S. [read post]
8 May 2008, 6:20 pm
Digitek is distributed by Mylan Pharmaceuticals, Inc. under the Bertek label. [read post]
16 May 2023, 7:51 am
In UCB Inc. v. [read post]
5 Jun 2011, 1:12 pm
Mensing Reverse Details Actavis v. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
22 Nov 2013, 2:40 pm
Actavis, Inc., et al., C.A. [read post]
14 Dec 2018, 1:16 pm
Actavis, 570 U.S. 136 (2013). [read post]
7 Jun 2007, 1:55 am
What constitutes patentable second medical use is occasionally a subject of dispute, a neat example being Actavis UK Ltd v Merck & Co Inc [2007] EWHC 1311 (Ch), an English Patents Court decision from Mr Justice Warren yesterday, available here on BAILII. [read post]
5 Aug 2011, 12:29 pm
Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]